Bellicum Pharma (BLCM) Selected for Inclusion in NASDAQ Biotechnology Index

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. ZETA

Go back to Bellicum Pharma (BLCM) Selected for Inclusion in NASDAQ Biotechnology Index

Bellicum to be Added to the NASDAQ Biotechnology Index

December 14, 2015 4:09 PM EST

HOUSTON--(BUSINESS WIRE)-- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for cancers and orphan inherited blood disorders, today announced that the Company has been selected for inclusion in the NASDAQ Biotechnology Index® (Nasdaq: NBI). This addition will be effective prior to market open on Monday, December 21, 2015.

... More